Gilead to end coronavirus drug trials, adding to access worry - researchers
By Deena Beasley
(Reuters) - Gilead Sciences Inc's two clinical studies of its potential coronavirus treatment remdesivir will wind down by the end of May, closing off a path of patient access to the antiviral medication, according to U.S. researchers involved in the studies.
……Read full article on Yahoo - World
Health News International
One-stop lifestyle app dedicated to making life in Singapore a breeze!
English
简体中文
Comments
Leave a comment in Nestia App